Nektar Therapeutics reported $599.48M in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
ALKERMES ALKS:US USD 1.05B 7.81M
Amgen AMGN:US USD 22.19B 1.88B
Astrazeneca AZN:US USD 20.22B 693M
Baxter International BAX:US USD 7.81B 72M
Biogen BIIB:US USD 9.77B 24.9M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Cara Therapeutics CARA:US USD 186.78M 10.61M
Eisai 4523:JP JPY 585.38B 35.57B
Esperion Therapeutics ESPR:US USD 261.78M 9.31M
Exelixis EXEL:US USD 1.84B 10.02M
Gilead Sciences GILD:US USD 15.23B 1.67B
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
Immunogen IMGN:US USD 330.42M 63.51M
IONIS PHARMACEUT IONS:US USD 2.15B 39.02M
Ironwood Pharmaceuticals IRWD:US USD 698.99M 81.17M
Karyopharm Therapeutics KPTI:US USD 222.68M 19.77M
Macrogenics MGNX:US USD 147.81M 19.82M
Mirati Therapeutics MRTX:US USD 1.23B 22.86M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Neurocrine Biosciences NBIX:US USD 1.21B 186.2M
Novartis NOVN:VX USD 36.95B 1.19B
Roche Holding ROG:VX 30.32B 5.31B
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Seattle Genetics SGEN:US USD 2.76B 19.04M
Takeda 4502:JP JPY 2.6T 149.67B
Teva Pharmaceutical TEVA:IT USD 11.45B 711M
Xencor XNCR:US USD 668M 82.06M
YTE INCY:US USD 3.82B 195.27M